ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Foundation for Sarcoidosis Research Sarc Fighter Podcast Surpasses 100,000 Downloads, Amplifying Voices in the Sarcoidosis Community

CHICAGO, July 21, 2025 (GLOBE NEWSWIRE) -- The Foundation for Sarcoidosis Research (FSR) is proud to celebrate a major milestone for the FSR Sarc Fighter Podcast, which has officially surpassed 100,000 downloads since its launch in 2020. Hosted by John Carlin, member of the FSR Board of Directors and sarcoidosis patient and advocate, the FSR Sarc Fighter Podcast is the first podcast dedicated entirely to sarcoidosis, a rare inflammatory disease with no known cure.

“I’m still amazed that the audience for the podcast has reached six figures,” said Carlin. “I started the podcast before the boom that came out of the pandemic as a way to help shine a light on our rare disease. I didn’t know if I’d be able to find enough guests to fill the time - or if I did, if anyone would be interested.”

Since the first episode aired on February 8, 2020, the FSR Sarc Fighter Podcast has become a trusted and heartfelt resource for the sarcoidosis community. Episodes feature all stakeholders in the rare disease space including clinicians, researchers, sarcoidosis patients, advocates and more to raise awareness, provide support, and build a better understanding of the disease.

“Partnering with FSR made a huge difference,” said Carlin. “It brought additional credibility to the show and helped me find top-tier researchers and thought leaders. I just want to thank everyone who has taken the time to join me on the show.”

As of today, the podcast has been downloaded more than 101,000 times, reflecting its impact and reach in raising awareness and fostering connection across the rare disease space.

“This milestone is extraordinary,” said Mary McGowan, President and CEO of FSR. “The FSR Sarc Fighter podcast has helped break down isolation, provide education, and bring hope to tens of thousands of people impacted by this disease. We are incredibly proud to support this platform and celebrate this momentous achievement with John Carlin and the sarcoidosis community.”

The FSR Sarc Fighter Podcast is currently available to stream on Apple Podcasts, Spotify, and PodBean and listeners can look forward to new episodes bi-weekly on Monday mornings. For more information, visit: www.stopsarcoidosis.org/sarc-fighter-podcast.

john carlin and podcast

About the Foundation for Sarcoidosis Research

The Foundation for Sarcoidosis Research (FSR) is the leading international organization dedicated to finding a cure for sarcoidosis and improving care for patients through research, education, and support. Since its founding in 2000, FSR has fostered over $8 million in sarcoidosis-specific research. Learn more at stopsarcoidosis.org.

About Sarcoidosis

Sarcoidosis is a rare inflammatory disease characterized by the formation of granulomas—clusters of immune cells—in one or more organs. The disease is complex, difficult to diagnose, and often presents with a wide range of symptoms. There is no known cure.

Media Contact:
Cathi Davis
cathi@stopsarcoidosis.org
312-341-5000

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/d3b0c508-74c6-4f9d-a22e-368ba1c876a2


Primary Logo

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.